A dry powder inhaler device supplier breaks even at about $208K in monthly revenue in the base case Here’s the quick math: monthly fixed costs are about $1465K, and contribution margin is about 705%, so break-even revenue is $1465K / 705% = about $208K Year 1 average monthly revenue is $162M, which leaves a planning cushion of about $141M above break-even The model reaches break-even in Month 1, but actual timing depends on device pricing, unit volume, supplier pricing, freight, fulfillment, and quality controls
Fixed costs$146.5K/mo
Payroll plus overhead
Contribution margin70.5%
After variable costs
Break-even revenue$207.7K/mo
Monthly target
Break-even timingMonth 1
Launch month
Break-even calculator
Test monthly revenue, variable expenses, and fixed costs to see where this inhaler supply business breaks even.
Money available to cover fixed costs$1,155,500
$1,617,500 revenue - $462,000 variable expenses
Margin ratio
71%
Covers fixed costs
Yes
Break-even chart Revenue Total costs
Which dry powder inhaler supply expenses are fixed and which move with sales?
Cost classification
Your break-even is reliable only if per-unit inputs, freight, and commissions move with sales while lease, certification, insurance, and base overhead stay monthly. Misclassify compliance or staffing, and Month 1 break-even can look safer than it is.
Expense
Cost
Break-Even Treatment
Common Mistake
Medical Grade Polymer
Variable
Apply the $0.25 per-unit input to each unit produced before calculating contribution margin.
Putting material spend in overhead and overstating margin as volume rises.
Direct Assembly Labor
Variable
Model per-unit assembly labor in unit economics, from $0.30 to $2.50 depending on device type.
Blending per-unit labor with salaried technicians and hiding true unit margin.
Outbound Freight and Logistics
Variable
Charge freight as a revenue-linked expense: 2.5% in Year 1 and 1.8% in Year 5.
Using a flat monthly freight budget when shipment volume drives the spend.
B2B Sales Commissions
Variable
Deduct commissions from revenue at 3.0% in Year 1, declining to 1.5% in Year 5.
Treating commissions like fixed payroll and overstating break-even sales coverage.
Cleanroom Facility Lease
Fixed
Include $22,000 per month in fixed overhead for the full operating period.
Spreading lease expense per unit and making low-volume months look too profitable.
ISO Certification Maintenance
Fixed
Use the $3,500 monthly amount as fixed overhead from Month 1 through Month 60.
Treating all compliance as variable; regulatory compliance fees are separate at 0.5% of revenue.
Manufacturing Technicians
Semi-fixed
Model staffing in capacity steps, rising from 4 FTE in Year 1 to 12 FTE in Year 5 at $65,000 salary.
Assuming technician payroll moves smoothly with every extra unit produced.
IT and Data Management plus Cloud Infrastructure
Semi-variable
Keep the $4,000 monthly IT base separate from cloud infrastructure at 0.6% of revenue.
Calling the whole digital support stack fixed and missing connected-device usage load.
How does break-even change from lean to full production for this inhaler supply model?
Scenario table
Lean uses the break-even floor, base uses the first-year run rate, and full uses the fifth-year scale. Fixed costs rise from about $146.5K a month to $235.2K, so revenue must climb, but the cushion gets much stronger.
Planning case figures are modeled assumptions, not a guarantee of actual demand, pricing, or margin.
Scenario
Monthly Revenue
Variable Costs
Fixed Costs
CM Ratio
Operating Profit
Break-Even Signal
Lean pre-commitment case
$0.21M
$0.06M
$0.15M
70.5%
$0.00M
Only covers fixed cost; one miss turns it negative.
Base launch planning case
$1.62M
$0.48M
$0.15M
70.5%
$0.99M
Holds about $1.41M above break-even each month.
Full scaled distribution case
$12.91M
$3.00M
$0.24M
76.8%
$9.68M
Strong cushion, but volume has to stay on plan.
What can push this inhaler supply business off break-even?
Stress test
Year 1 revenue sits well above the $208K monthly break-even, with about $1.41M of cushion. The main risk is slower adoption plus higher freight, rework, or fixed overhead, because those three push the floor up fast and can shrink the buffer month by month.
Stress Case
Changed Assumption
Break-Even Revenue
Revenue Gap
Risk Signal
Current plan
No change.
$208K/mo
$1.41M cushion
Year 1 stays well above break-even.
Revenue shortfall
Monthly revenue comes in $100K below plan.
$208K/mo
$1.31M cushion
A slower launch still clears break-even, but the room shrinks.
Fixed-cost pressure
Monthly fixed costs rise by $100K.
$350K/mo
$1.27M cushion
Lease, compliance, or staffing creep pushes the floor up fast.
Margin pressure
Freight and rework add $100K of monthly variable cost.
$350K/mo
$1.27M cushion
Freight, commissions, or rework drift can erode the buffer.
What should you verify before you lock the cleanroom lease and launch spend?
Founder checklist
Check the launch mix, supplier terms, and cash cushion before you lock the lease and order inventory. The model only works if you can carry $146.45K of monthly fixed load, keep at least $876K cash in Month 1, and fund the $2.375M capex separately.
1Supplier termsNet terms
Get supplier terms in writing before the first inventory order, so cash does not get tied up before sales start.
2Year 1 mix1.905M units
Confirm the opening-year volume plan is really 1.2M single-dose, 450K multi-dose, 150K pediatric, 80K high-payload, and 25K connected units, because break-even depends on that mix.
3Unit margin78.6%-85.3%
Verify that the price deck still clears unit cost, because the modeled gross margin runs from 78.6% on multi-dose to 85.3% on connected units before overhead.
4QC stack5 controls
Make sure testing, sterilization, regulatory compliance, environmental monitoring, and batch record review are in place before shipment, or revenue can get stuck behind hold-and-release delays.
5Staffing ramp10 FTE
Check that the opening team can cover engineering, QA, regulatory, sales, and manufacturing at 10.0 FTE in Year 1, because shortages here slow output and raise overtime risk.
6Fixed load$146.45K/mo
Keep at least $876K in Month 1, and do not sign the $22K lease until pipeline and regulatory readiness are clear; approve the $2.375M launch capex separately from break-even.